ResearchMoz

Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-05-14
No. Of Pages » 93
 
 Contraceptive drugs and devices are temporary birth control methods and function majorly by altering the mechanism of ovulation and acting as physical barriers between the sperm and ovary. This report holds the market estimation of the global contraceptives market in terms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contraceptives market. 
   
 The overall contraceptives market is categorized on the basis of products into two major categories namely contraceptive drugs and contraceptive devices. The contraceptive drugs market is further sub-segmented into contraceptive pills, injectables and...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Growing Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet Contraceptive Needs
3.1.1.2 Government and NGO Initiatives to Promote Contraceptive Products
3.1.1.3 Implementation of the Patient Protection Act or the Affordable Care Act
3.1.1.4 Rising Global Prevalence of Sexually Transmitted Infections (STI)
3.1.2 Impact Analysis of Market Drivers for the Global Contraceptives Market
3.1.3 Market Restraints
3.1.3.1 Side Effects Associated with the use of Contraceptive Drugs and Devices
3.1.3.2 Rapidly Aging Population and Rising Prevalence of Infertility
3.1.4 Impact Analysis of Market Restraints for the Global Contraceptives Market
3.1.5 Market Opportunities
3.1.5.1 Presence of Strong Contraceptives Pipeline
3.1.5.1.1 Male Contraceptive Drugs
3.1.5.1.2 AG200-15 Topical Contraceptive Patch
3.1.5.1.3 FC Patch Low
3.1.5.1.4 Pill-Plus
3.1.5.1.5 Other Products in Pipeline
3.1.5.2 Presence of Large Unmet Contraceptive Needs in Emerging Asian and African Economies
3.2 Porter’s Five Forces Analysis: Global Contraceptives Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
3.4 Global Contraceptives Market, 2010 – 2018 (USD Million)

Chapter 4 Global Contraceptives Market, by Products
4.1 Overview
4.2 Global Contraceptive Drugs Market
4.2.1 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
4.2.2 Global Oral Contraceptive Pills Market
4.2.2.1 Competitive Landscape: Global Oral Contraceptives Market, 2011
4.2.2.2 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
4.2.3 Global Contraceptive Injectables Market
4.2.3.1 Competitive Landscape: Global Contraceptive Injectables Market, 2011
4.2.3.2 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
4.2.4 Global Topical Contraceptives Market
4.2.4.1 Competitive Landscape: Global Topical Contraceptives Market
4.2.4.2 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
4.3 Global Contraceptive Devices Market
4.3.1 Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.1 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.2 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
4.3.2 Global Female Contraceptive Devices Market
4.3.2.1 Global Female Condoms Market
4.3.2.1.1 Global Female Condoms Market, 2010 – 2018 (USD Million)
4.3.2.2 Global Contraceptive Diaphragms Market
4.3.2.2.1 Global Contraceptive Diaphragms Market, 2010 – 2018 (USD Million)
4.3.2.3 Global Contraceptive Sponges Market
4.3.2.3.1 Competitive Landscape: Global Contraceptive Sponges Market
4.3.2.3.2 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
4.3.2.4 Global Contraceptive Vaginal Rings Market
4.3.2.4.1 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
4.3.2.5 Global Intrauterine Devices (IUD) Market
4.3.2.5.1 Global Copper IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.2 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.3 Competitive Landscape: Global IUD Market, 2011
4.3.2.6 Global Sub-dermal Contraceptive Implants Market
4.3.2.6.1 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
4.3.2.6.2 Competitive Landscape: Global Sub-dermal Contraceptive Implants Market

Chapter 5 Global Contraceptives Market, by Geography
5.1 Overview
5.2 North America Contraceptives Market
5.2.1 North America Contraceptives Market, 2010 – 2018 (USD Million)
5.2.2 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.3 Europe Contraceptives Market
5.3.1 Europe Contraceptives Market, 2010 – 2018 (USD Million)
5.3.2 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.4 Asia-Pacific Contraceptives Market
5.4.1 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
5.4.2 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.5 Rest of the World (RoW) Contraceptives Market
5.5.1 RoW Contraceptives Market, 2010 – 2018 (USD Million)
5.5.2 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)

Chapter 6 Recommendations
6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies
6.2 Making Rigorous R&D Initiatives
6.3 Investing in Marketing Campaigns to Elevate Customer Awareness
6.4 Tracking patent expiration of Branded Products

Chapter 7 Company Profiles
7.1 Merck & Co.
7.1.1 Company Profile
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategy
7.1.5 Recent Developments
7.2 Bayer  HealthCare AG
7.2.1 Company Profile
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Church & Dwight, Co. Inc.
7.3.1 Company Profile
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategy
7.3.5 Recent Developments
7.4 Warner Chilcott Company, Inc.
7.4.1 Company Profile
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategy
7.4.5 Recent Developments
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategy
7.5.5 Recent Developments
7.6 Agile Therapeutics Inc.
7.6.1 Company Overview
7.6.2 Business Strategy
7.6.3 Product Portfolio
7.6.4 Recent Developments
7.7 BioSante Pharmaceuticals Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Business Strategy
7.7.4 Product Portfolio
7.7.5 Recent Developments
7.8 Mayer Laboratories, Inc.
7.8.1 Company Overview
7.8.2 Business Strategy
7.8.3 Product Portfolio
7.8.4 Recent Developments
7.9 Pantarhei Bioscience B.V.
7.9.1 Company Overview
7.9.2 Business Strategy
7.9.3 Product Portfolio
7.9.4 Recent Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Product Portfolio
7.10.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Contraceptives Market
TABLE 2 Impact Analysis of Market Drivers for the Global Contraceptives Market
TABLE 3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
TABLE 4 Impact Analysis of Market Restraints for the Global Contraceptives Market
TABLE 5 Contraceptive Products in Pipeline, Product Status and Manufacturer Names
TABLE 6 Global Contraceptives Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 7 Global Contraceptives Drugs Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 8 List of Latest Oral Contraceptive Pill Approvals, 2010 – 2012
TABLE 9 Global Female Contraceptive Devices Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 10 Global IUD Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 11 Global Contraceptives Market, by Geography, 2010 – 2018 (USD Million)
TABLE 12 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 13 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 14 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 15 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)

List of Figures


FIG. 1 Market Segmentation: Global Contraceptives Market
FIG. 2 Global Contraceptives Market, by Product Types, 2011 (USD Million)
FIG. 3 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 4 Average percentage of women with unmet contraceptive needs in the Southeast Asian, South Central Asian and Sub-Saharan African countries, 2011 (%)
FIG. 5 Porter’s Five Forces Analysis: Global Contraceptives Market
FIG. 7 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
FIG. 8 Global Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 9 Comparative Analysis of the Global Contraceptives Market, by Products, 2011 & 2018 (%)
FIG. 10 Comparative Analysis of the Global Contraceptive Drugs Market, by Product Types, 2011 & 2018 (%)
FIG. 11 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
FIG. 12 Competitive Landscape by Market Players: Global Oral Contraceptives Market, 2011 (%)
FIG. 13 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
FIG. 14 Competitive Landscape, by Brands: Global Contraceptive Injectables Market, 2011
FIG. 15 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
FIG. 16 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 17 Comparative Analysis of the Global Contraceptive Devices Market, by Product Types, 2011 & 2018 (%)
FIG. 18 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
FIG. 19 Global Female Condoms Market, 2010 – 2018 (USD Million)
FIG. 20 Global Female Diaphragms Market, 2010 – 2018 (USD Million)
FIG. 21 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
FIG. 22 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
FIG. 23 Comparative Analysis of the Global IUD Market, by Product Types, 2011 & 2018 (%)
FIG. 24 Global Copper IUD Market, 2010 – 2018 (USD Million)
FIG. 25 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
FIG. 26 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
FIG. 27 Comparative Analysis of the Global Contraceptives Market by Geography, 2011 & 2018 (%)
FIG. 28 North America Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 29 Europe Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 30 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 31 RoW Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 32 Annual Revenues: Merck & Co.,  2009 - 2011 (USD million)
FIG. 33 Annual Revenues: Bayer HealthCare AG., 2009 – 2011 (USD Million) (1 Euro = 1.30 USD)
FIG. 34 Annual revenues: Church & Dwight Co. Inc., 2009 – 2011 (USD Million)
FIG. 35 Annual Revenues: Warner Chilcott Co. Inc.,   2009 - 2011 (USD million)
FIG. 36 Annual revenues: Pfizer Inc., 2009 – 2011 (USD Million)
FIG. 37 Annual Revenues: BioSante Pharmaceuticals Inc., 2009 – 2011 (USD Thousands)
FIG. 38 Annual Revenues: Teva Pharmaceutical Industries Ltd., 2009 – 2011 (USD Million)

Upcoming Reports:

Dolomite Mining Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
With the rapid increase in the construction and mining activities for dolomite, the market for dolomite mining and equipments has the potential to exhibit significant growth in the future. According to Mineral planning factsheet, out of a total of 12.2 Million tons of Dolomite mined in the United Kingdom, around 10.8 Million tons is used in the construction industry. Nearly 50 % of world’s carbonate reserves are in dolomite and these dolomite reserves can also host a significant amount of hydrocarbons. Hence with an abundance of reserves, diverse applications and easy mining...
Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Antipsychotics are drugs used in the treatment of brain disorders such as schizophrenia, bipolar disorder, and severe depression. According to the New York Times, antipsychotics are one of the largest types of prescribed drugs in the United States with over 3.1 million Americans accounting for a market worth USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This brings a market of about 7.5 million people suffering from combined disorders of schizophrenia, bipolar disorder, dementia,...
Thermal Energy Storage (TES) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Thermal energy storage (TES) stores excess thermal energy in a storage medium and supplies it back in later use. TES can be utilized on an individual, multiuser, district or even on larger scale.TES systems provide balance between day time and night time or summer time and winter time. TES is commonly used in air conditioning activities of commercial buildings, where heat is stored during cooling cycles and recovered during heating cycles. It also helps in energy saving hence, TES makes air conditioning process sustainable. TES can also be accompanied by solar power. With the help of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...